Abstract 118P
Background
Gastric cancer (GC) is a fourth leading cancer in Nepal and third most common cause for cancer-related mortality. This case-control study was carried out to find an association of behavioral and dietary factors in gastric cancer development among adult Nepali populations.
Methods
This study was conducted from Jan 2021 to Dec 2021 at Patan Academy of Health Sciences(PAHS), Lalitpur Nepal. In total, 89 patients with GC and 89 patients not having GC were studied as controls. Data were collected via face to face interview using a standard structured questionnaire, posing question about socio-demographic, behavioral and dietary habits, and clinical factors. Logistic regression method was used to calculate the odds ratio.
Results
The most common age group for both case and control was 55 to 65 years. The results showed that regular intake of red meat, duration of smoking, smokeless tobacco, fast food and fatty food, and family history of any type of cancer were directly associated with the risk of stomach cancer. On the contrary intake of chicken and vegetables, tea and coffee, regular walking and sports habit have inverse association with stomach cancer. Adjusted odds ratio shows, regular consumption of red meat have 2 times more risk (OR=2.0) of developing stomach cancer compare to irregular meat consumption. Moreover, person with history of H. pylori infection found 53% (OR=7.263; 95% CI; 3.614-14.597) more likely to develop stomach cancer.
Conclusions
Nepali studies on this topic are limited and more research is required to understand the etiology, need for development of suitable screening test, to demarcate high-risk population and to develop and evaluate the effect of primary prevention programs.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
48P - Long-term clinical outcomes after the second metastasectomy in patients (pts) with resected metastatic colorectal cancer (mCRC)
Presenter: Songji Choi
Session: Poster viewing 02
49P - Ramucirumab beyond progression plus TAS 102 in patients with advanced or metastatic adenocarcinoma of the stomach or the gastroesophageal junction, after treatment failure on a ramucirumab based therapy: Final results of the phase II RE-ExPEL study
Presenter: Thorsten Goetze
Session: Poster viewing 02
50P - Linear tumor regression of rectal cancer in daily MRI during preoperative chemoradiotherapy: An insight of tumor regression velocity for personalized cancer therapy
Presenter: Sea-Won Lee
Session: Poster viewing 02
51P - Efficacy and safety of sintilimab as first-line therapy in patients with microsatellite instability-high metastatic colorectal cancer: A real-world study
Presenter: Caiyun Nie
Session: Poster viewing 02
53P - Baseline PET/CT deep radiomics signature apply for identifying bevacizumab sensitivity of RAS-mutant colorectal cancer liver metastases patients
Presenter: Wenju Chang
Session: Poster viewing 02
54P - Efficacy of total neoadjuvant therapy (TNT) in rectal cancer: A meta-analysis of randomized controlled trials
Presenter: Yakup Ergün
Session: Poster viewing 02
55P - Biodegradable and biocompatible 3D-printed scaffolds loaded with chemotherapy drugs: A new horizon for treatment of colon cancer with diffuse intraperitoneal metastasis
Presenter: Amirhosein Kefayat
Session: Poster viewing 02
56P - Clinico-pathological profile of adolescent and young adult colorectal cancer patients: Multicentre collaborative registry data from India
Presenter: Soumya Surath Panda
Session: Poster viewing 02